Logo
x

Search

Subscribe Now

Telix

Telix Reports the Acquisition of ARTMS and its Advanced Isotope Production Platform

Telix Reports the Acquisition of ARTMS and its Advanced Isotope Production Platform

  • March 5, 2024
Telix to Acquire QSAM Biosciences to Enhance its Oncology Segment

Telix to Acquire QSAM Biosciences to Enhance its Oncology Segment

  • February 8, 2024
Telix Reports the First Patient Dosing of TLX101 in P-I Study (IPAX-2) for Newly Diagnosed Glioblastoma

Telix Reports the First Patient Dosing of TLX101 in P-I Study (IPAX-2) for Newly Diagnosed Glioblastoma

  • August 8, 2023
Telix Presented P-III Results from TLX250-CDx for Kidney Cancer Imaging Study at the ASCO GU 2023

Telix Presented P-III Results from TLX250-CDx for Kidney Cancer Imaging Study at the ASCO GU 2023

  • February 20, 2023
Telix Reports the First Patient Dosing of TLX101 in P-II (IPAX-Linz) Study for the Treatment of Glioblastoma

Telix Reports the First Patient Dosing of TLX101 in P-II (IPAX-Linz) Study for the Treatment of Glioblastoma

  • November 22, 2022
Telix Reports the Completion of Patient Enrollment in P-III (ZIRCON) Study of TLX250-CDx for the Treatment of Clear Cell Renal Cell Cancer

Telix Reports the Completion of Patient Enrollment in P-III (ZIRCON) Study of TLX250-CDx for the Treatment of Clear Cell Renal Cel...

  • July 11, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.